ID: ALA606075

Max Phase: Preclinical

Molecular Formula: C16H24N2O15P2

Molecular Weight: 546.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1ccn(C2O[C@H](COP(=O)(O)OP(=O)(O)CC3=CC(O)C(O)C(CO)O3)[C@@H](O)[C@H]2O)c(=O)[nH]1

Standard InChI:  InChI=1S/C16H24N2O15P2/c19-4-9-12(22)8(20)3-7(31-9)6-34(26,27)33-35(28,29)30-5-10-13(23)14(24)15(32-10)18-2-1-11(21)17-16(18)25/h1-3,8-10,12-15,19-20,22-24H,4-6H2,(H,26,27)(H,28,29)(H,17,21,25)/t8?,9?,10-,12?,13-,14-,15?/m1/s1

Standard InChI Key:  QPKXYGVIVBDPHQ-WEDSKWJTSA-N

Associated Targets(non-human)

Beta-1,4-galactosyltransferase 1 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 546.32Molecular Weight (Monoisotopic): 546.0652AlogP: -3.53#Rotatable Bonds: 9
Polar Surface Area: 267.53Molecular Species: ACIDHBA: 14HBD: 8
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.90CX Basic pKa: CX LogP: -5.01CX LogD: -9.62
Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.14Np Likeness Score: 1.45

References

1. Schmidt RR, Frische K.  (1993)  A new galactosyl transferase inhibitor,  (8): [10.1016/S0960-894X(00)80055-4]

Source